1. Home
  2. CHY vs BVS Comparison

CHY vs BVS Comparison

Compare CHY & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Convertible and High Income Fund

CHY

Calamos Convertible and High Income Fund

N/A

Current Price

$10.61

Market Cap

960.4M

Sector

Finance

ML Signal

N/A

Logo Bioventus Inc.

BVS

Bioventus Inc.

N/A

Current Price

$10.88

Market Cap

910.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHY
BVS
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
960.4M
910.2M
IPO Year
2003
2016

Fundamental Metrics

Financial Performance
Metric
CHY
BVS
Price
$10.61
$10.88
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $16.60
AVG Volume (30 Days)
201.8K
★ 606.9K
Earning Date
01-01-0001
11-02-2026
Dividend Yield
★ 10.11%
N/A
EPS Growth
N/A
★ 163.46
EPS
N/A
★ 0.60
Revenue
N/A
★ $568,087,000.00
Revenue This Year
N/A
$4.72
Revenue Next Year
N/A
$6.41
P/E Ratio
★ N/A
$18.12
Revenue Growth
★ N/A
N/A
52 Week Low
$10.41
$6.47
52 Week High
$13.91
$15.89

Technical Indicators

Market Signals
Indicator
CHY
BVS
Relative Strength Index (RSI) 35.06 33.79
Support Level $10.41 $8.21
Resistance Level $12.21 $11.00
Average True Range (ATR) 0.22 0.66
MACD 0.01 -0.24
Stochastic Oscillator 5.95 15.20

Price Performance

Historical Comparison
CHY
BVS

About CHY Calamos Convertible and High Income Fund

Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: